Journal of Comprehensive Pediatrics

Published by: Kowsar

Use of Recombinant Factor VIIa Utilization Among a Hospitalized Pediatric Population

Nathan E Thompson 1 , * , Melissa Meuler 2 and John P Scott 3
Authors Information
1 Department of Pediatrics Section of Pediatric Critical Care, Medical College of Wisconsin, Milwaukee, USA
2 Pharmacy Practice Resident Children’s Hospital of Wisconsin, Wisconsin, USA
3 Departments of Anesthesiology and Pediatrics, Sections of Pediatric Anesthesiology and Pediatric Critical Care, Wisconsin, USA
Article information
  • Journal of Comprehensive Pediatrics: August 31, 2015, 6 (3); e25505
  • Published Online: August 24, 2015
  • Article Type: Research Article
  • Received: February 20, 2015
  • Revised: May 24, 2015
  • Accepted: June 3, 2015
  • DOI: 10.17795/compreped-25505

To Cite: E Thompson N, Meuler M, P Scott J. Use of Recombinant Factor VIIa Utilization Among a Hospitalized Pediatric Population, J Compr Ped. 2015 ; 6(3):e25505. doi: 10.17795/compreped-25505.

Copyright © 2015, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Hedner U. Factor VIIa and its potential therapeutic use in bleeding-associated pathologies. Thromb Haemost. 2008; 100(4): 557-62[PubMed]
  • 2. Logan AC, Goodnough LT. Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting. Hematology Am Soc Hematol Educ Program. 2010; 2010: 153-9[DOI][PubMed]
  • 3. [package insert] Coagulation Factor VIIa (Recombinant). 2006;
  • 4. Guzzetta NA, Russell IA, Williams GD. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. Anesth Analg. 2012; 115(2): 364-78[DOI][PubMed]
  • 5. Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, et al. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. J Clin Anesth. 2014; 26(3): 204-11[DOI][PubMed]
  • 6. Witmer CM, Huang YS, Lynch K, Raffini LJ, Shah SS. Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study. J Pediatr. 2011; 158(5): 820-825 e1[DOI][PubMed]
  • 7. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006; 295(3): 293-8[DOI][PubMed]
  • 8. Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, et al. Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med. 2011; 154(8): 529-40[DOI][PubMed]
  • 9. Ponschab M, Landoni G, Biondi-Zoccai G, Bignami E, Frati E, Nicolotti D, et al. Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2011; 25(5): 804-10[DOI][PubMed]
  • 10. Blatny J, Mathew P, Monagle P, Ovesna P, Fiamoli V. Safety and efficacy of recombinant activated factor VII in nonhemophilia children with severe or life-threatening bleeding: a report from the SeveNBleeP registry. Blood Coagul Fibrinolysis. 2014; 25(4): 326-32[DOI][PubMed]
  • 11. McQuilten ZK, Barnes C, Zatta A, Phillips LE, Haemostasis Registry Steering C. Off-label use of recombinant factor VIIa in pediatric patients. Pediatrics. 2012; 129(6)-40[DOI][PubMed]
  • 12. Pychynska-Pokorska M, Pagowska-Klimek I, Krajewski W, Moll JJ. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2011; 25(6): 987-94[DOI][PubMed]
  • 13. Hedner U, Kristensen H, Berntorp E, Ljung R, Petrini P, Tengborn L. Pharmacokinetics of rFVIIa in children. Haemophilia. 1998; 4(3): 355
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments